In order to contribute to the understanding to the contradictory results in different studies, we compared the effects of E2, the ERα specific agonist 16α-LE2, and raloxifene on cardiac hypertrophy, systolic function, and fibrosis in a long term model of pressure overload-induced cardiac hypertrophy. This evidence concerns the gene ESR1 and cardiac hypertrophy.